Back to search

Article

A Randomized Controlled Trial of Ivermectin Monotherapy Versus Hydroxychloroquine, Ivermectin, and Azithromycin Combination Therapy in Covid-19 Patients in Nigeria

2021-10-01

Abstract excerpt

<title>Abstract</title> <p>The efficacy of ivermectin (IVM) against SARS-CoV-2 has been demonstrated in vitro, while several clinical studies suggest that it is efficacious and safe in reducing morbidity and mortality. Hydroxychloroquine <bold>H</bold>CQ, <bold>I</bold>VM and azithromycin AZM (HIA therapy) are being used in several low- and middle-income countries (LMICs) where more expensive medications such as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4ca62183-0c22-5586-bb77-0aff8e7725c1
DOI
10.21203/rs.3.rs-950352/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Randomized Controlled Trial of Ivermectin Monotherapy Versus Hydroxychloroquine, Ivermectin, and Azithromycin Combination Therapy in Covid-19 Patients in NigeriaDOI 10.21203/rs.3.rs-950352/v1
Select a neighboring publication to make it the new centre.